Navigation Links
Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures
Date:5/2/2008

Emerging Trends Discussed at American Society for Aesthetic Plastic Surgery's Annual Meeting

NEW YORK, May 2 /PRNewswire-USNewswire/ -- New techniques and devices for surgical and nonsurgical cosmetic enhancement are being introduced at a rapid pace, but do these innovations really deliver what they promise? Are the results of minimally invasive treatments, offering the benefit of little or no downtime, comparable to more extensive procedures? Are these new modalities safe and cost-effective for patients? These are the questions that leading aesthetic plastic surgeons will explore during the Hot Topics seminar at the annual meeting of the American Society for Aesthetic Plastic Surgery (ASAPS), May 2-6 in San Diego, CA.

"Presentations at the annual Hot Topics seminar focus on some of the most intriguing innovations in both surgical and nonsurgical cosmetic treatments," says New York plastic surgeon Alan Gold, MD, president of the Aesthetic Surgery Education and Research Foundation (ASERF), co-sponsor of Hot Topics with the Plastic Surgery Educational Foundation (PSEF). "Every year the Hot Topics seminar proves to be one of the most popular sessions, so this year we there will be two Hot Topics programs - one at the beginning of the Meeting and one at the end."

The following are among the presentations included in this year's Hot Topics program:

-- Injection Lipolysis (Otherwise known as Mesotherapy or LipoDissolve):

V. Leroy Young, MD, a plastic surgeon in St. Louis, IL, will be

discussing ASERF's Clinical Trial on injection lipolysis. The

trial will study 10 patients receiving four injection lipolysis

treatments to one side of their abdomen. MRIs and biopsies will be

performed on the patients, and photographs of the patients will be taken

before and after injections are administered. The goal of this study is

to find out if injection lipolysis actually works -- and how exactly it

works. Safety concerns will be reviewed during the study.

-- Lipo-Transfer: Kotaro Yoshimura, MD, a plastic surgeon from Tokyo, will

be presenting new advances in Lipo Transfer. One common problem with

this procedure is the difficulty predicting the survival rate of

transplanted fat or the risk of fibrosis and calcification. To overcome

the problem, Dr. Yoshimura has developed a strategy called Cell-Assisted

Lipotransfer (CAL), which employs patients' adipose-derived stem

cells and can be applied to breast augmentation. He expects that this

technique will improve the survival rate and prevent post operative

atrophy of transplanted fat tissue.

-- Laser-Assisted Lipolysis: Arturo Prado, MD, Barry E. DiBernardo, MD,

and Jeffrey M. Kenkel, MD, will present on laser-assisted (fat

destroying) Lipolysis. Dr. Prado, a plastic surgeon in Chile, will

report on his randomized double-blind study that compared traditional

lipoplasty and laser-assisted lipoplasty. Dr. DiBernardo (Cutera,

Cynosure, Lumensis and Apira Science), a plastic surgeon in Montclair,

NJ, is going to discuss the first preliminary clinical trial of

SmartLipo. Dr. Kenkel (Palomar), a plastic surgeon in Dallas, TX, will

discuss his clinical experience with CoolLipo and ProLipo.

As plastic surgeons concerned about patient safety, we want to be sure that the treatments we recommend are backed by good science and sufficient clinical experience," says Foad Nahai, MD, ASAPS President and a plastic surgeon in Atlanta, GA. "Many of these innovations in aesthetic surgery may prove to be widely beneficial, but at the beginning they must be used cautiously and, of course, only with the patient's full informed consent.

The American Society for Aesthetic Plastic Surgery (ASAPS), the Aesthetic Surgery Education and Research Foundation (ASERF), and the Public Surgery Education Foundation (PSEF), do not advocate or endorse the procedures or technologies presented at the Hot Topics seminar. This seminar is strictly for the purposes of research and education in cosmetic plastic surgery. The reporting, advertising or clinical use of these procedures and technologies should be conducted cautiously, responsibly and with full disclosure of their unproven nature.

Hot Topics

Friday, May 2, 12:30-4:30pm

The Best of Hot Topics - Lipo-Transfer and SmartLipo

Tuesday, May 6, 3:45

Moderators: William P. Adams, Jr. MD of Dallas, TX

Joe M. Gryskiewicz, MD, of Burnsville, MN

Panelists: Kotaro Yoshimura, MD, of Japan

Arturo Prado, MD, of Chile

Barry DiBernardo, MD, of Montclair, NJ

Jeffrey Kenkel, MD, of Dallas, TX

V. Leroy Young, MD, of St. Louis, MO

PRESENTERS are available for interviews.

CONTACT THE ASAPS COMMUNICATIONS STAFF.

About ASAPS

The 2400-member American Society for Aesthetic Plastic Surgery (ASAPS) is the only plastic surgery organization devoted entirely to the advancement of cosmetic surgery. ASAPS is recognized throughout the world as the authoritative source for cosmetic surgery education. U.S. members are certified by the American Board of Plastic Surgery. Canadian members are certified in plastic surgery by the Royal College of Physicians and Surgeons of Canada.

Toll-free referral line: 888.ASAPS.11 (272.7711). Web site: http://www.surgery.org


'/>"/>
SOURCE American Society for Aesthetic Plastic Surgery
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Miami Plastic Surgeon Offers Hope to Acne Scarred Patients
2. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
3. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
4. Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients
5. Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health
6. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
7. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
8. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
9. Multi Merci Trial Results Published in Peer Reviewed Journal
10. FDA Grants Priority Review for PROMACTA(R) (eltrombopag)
11. FDA Grants Priority Review for ACIPHEX(R) (rabeprazole sodium) sNDA for Short-Term Treatment of GERD in Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017  CVS Pharmacy, the retail division of ... store design to enhance the retail customer experience ... products and expanded beauty selections paired with informational ... new offerings. Together with its innovative digital programs, ... customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2014 ... ... US$ 7,167.6 Mn in 2015, and is expected to reach ... 5.6% from 2016 to 2024. The global ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
Breaking Medicine Technology:
(Date:4/28/2017)... New york (PRWEB) , ... April 28, 2017 ... ... pleased to announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice ... training and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique ...
(Date:4/28/2017)... Edinburg, Texas (PRWEB) , ... April 28, 2017 , ... ... a plaque in recently to the labor and delivery team at Women’s Hospital at ... generous mothers who give birth at the hospital and decide to donate. , ...
(Date:4/28/2017)... Linda, Ca (PRWEB) , ... April 28, 2017 ... ... with cardiac or hERG liability could substantially improve drug safety and minimize the ... be provided for validating ion channel inhibition using cell lines and for cardiac ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Bill Howe started ... in the coastal communities. After Tina Howe joined the team, the Bill Howe brand ... honest services at affordable rates, and giving back to the San Diego community in ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... are conducting a pilot study of ActiGraph’s CentrePoint Data Hub in ... a leading provider of clinical-grade wearable activity and sleep monitoring solutions for the ...
Breaking Medicine News(10 mins):